Retrospective analysis of clinical findings and outcome of cats with suspected rattlesnake envenomation in Southern California: 18 cases (2007-2010)

被引:8
作者
Hoose, Jennifer A. [1 ]
Carr, Amy
机构
[1] Calif Vet Specialists, Ontario, CA 91761 USA
关键词
antivenom; antivipmyn; crofab; crotalid; echinocytes; feline; UNITED-STATES; SNAKE-VENOMS; DOGS; MANAGEMENT; ANTIVENOM; HORSES; BITES;
D O I
10.1111/vec.12051
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective To evaluate treatment and survival rates of cats with suspected rattlesnake envenomation. Design Retrospective study. Setting Veterinary emergency referral hospital in Southern California. Animals Client-owned animals. Interventions None. Measurements and main results Eighteen cats were treated for suspected rattlesnake envenomation between January 2007 and August 2010. There were 3 fatalities and 15 cats survived (16% mortality rate). Two cases developed pelvic limb paresis 3-4 days post envenomation. There were no apparent adverse reactions to treatment with antivenom. Conclusions Cats are presented infrequently for treatment of envenomation compared to dogs. Envenomation in cats should be treated according to guidelines established for people and dogs and administration of antivenom does not appear to be associated with adverse events. The mortality rate in this study was found to be 16%, which is higher than the mortality rate reported for dogs suspected of rattlesnake envenomation in a similar region (4.1%). Pelvic limb paresis may develop 3-4 days post envenomation but can resolve within 24 hours.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 29 条
[1]  
[Anonymous], 2001, PACK INS ANT CROT PO
[2]   Overview and controversies in the medical management of pit viper envenomation in the dog [J].
Armentano, Robert A. ;
Schaer, Michael .
JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2011, 21 (05) :461-470
[3]   Crotaline Fab antivenom for treatment of children with rattlesnake envenomation [J].
Behm, MO ;
Kearns, GL .
PEDIATRICS, 2003, 112 (06) :1458-1459
[4]  
Bush SP, 1999, WILD ENVIRON MED, V10, P247, DOI 10.1580/1080-6032(1999)010[0247:NAWSSP]2.3.CO
[5]  
2
[6]   SNAKE-VENOM VARIABILITY - METHODS OF STUDY, RESULTS AND INTERPRETATION [J].
CHIPPAUX, JP ;
WILLIAMS, V ;
WHITE, J .
TOXICON, 1991, 29 (11) :1279-1303
[7]   COMPARISON OF A NEW OVINE ANTIGEN-BINDING FRAGMENT (FAB) ANTIVENIN FOR UNITED-STATES CROTALIDAE WITH THE COMMERCIAL ANTIVENIN FOR PROTECTION AGAINST VENOM-INDUCED LETHALITY IN MICE [J].
CONSROE, P ;
EGEN, NB ;
RUSSELL, FE ;
GERRISH, K ;
SMITH, DC ;
SIDKI, A ;
LANDON, JT .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 53 (05) :507-510
[8]   A randomized multicenter trial of crotalinae polyvalent immune fab (Ovine) antivenom for the treatment for crotaline snakebite in the United States [J].
Dart, RC ;
Seifert, SA ;
Boyer, LV ;
Clark, RF ;
Hall, E ;
McKinney, P ;
McNally, J ;
Kitchens, CS ;
Curry, SC ;
Bogdan, GM ;
Ward, SB ;
Porter, RS .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (16) :2030-2036
[9]  
Dickinson CE, 1996, J AM VET MED ASSOC, V208, P1866
[10]   Rattlesnake envenomation in horses: 58 cases (1992-2009) [J].
Fielding, C. Langdon ;
Pusterla, Nicola ;
Magdesian, K. Gary ;
Higgins, Jill C. ;
Meier, Chloe A. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2011, 238 (05) :631-635